ANDA 79084, held by Apotex Inc. Gatifloxacin.
As of Nov 16, 2026, ANDA 79084 (Gatifloxacin), held by Apotex Inc, was first approved by FDA on Aug 19, 2011, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 19, 2011 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Gatifloxacin0.3% · solution/drops;ophthalmic | Gatifloxacin | Discontinued |
| Sep 21, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Aug 19, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters